Dysregulation of CES1 has been associated with the development of diseases such as diabetes, obesity, and cancer [24,25], with abnormal expression of CES1 observed in various cancers including liver [26], lung [27], colorectal [28], and prostate [25] cancer. This evidence concerns the gene CES1 and obesity due to melanocortin 4 receptor deficiency.